• Diagnosis​ Info ​and​ ​General​ ​Questions

  Emmaus, US Bioservices Offer New SCD Treatment Adherence Program

  Posted by sickle-cell-forum-administrator on February 5, 2020 at 7:14 pm

  

  Biopharmaceutical Emmaus Life Sciences has teamed up with specialty pharmacy US Bioservices to offer a treatment adherence program for SCD patients. Read more about it here.

  What are your thoughts on this news?

  sickle-cell-forum-administrator replied 4 years, 2 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply